Paiva-Fonseca F, Santos-Silva AR, Della-Coletta
R, Vargas PA, Lopes MA. Alendronate-associated osteonecrosis of the jaws: A
review of the main topics. Med Oral Patol Oral
Cir Bucal. 2014 Mar 1;19 (2):e106-11.
doi:10.4317/medoral.19094
http://dx.doi.org/doi:10.4317/medoral.19094
|
1. Madrid
C, Sanz M. What impact do systemically
administrated bisphosphonates have on oral implant
therapy? A systematic review. Clin Oral Impl Res. 2009;20:87-95. |
|
|
|
|
|
2. Shin
EY, Kwon YH, Herr Y, Shin SI, Chung JH. Implant failure associated with oral bisphosphonate-related osteonecrosis
of the jaw. J Periodontal
Implant Sci. 2010;40:90-5. |
|
|
|
|
|
3. Bauer
JS, Beck N, Kiefer J, Stockmann P, Wichmann M, Eitner S. Awareness
and education of patients receiving bisphosphonates.
J Craniomaxillofac Surg. 2012;40:277-82. |
|
|
|
|
|
4. Diz P, Limeres J, Fedele S, Seoane J, Diniz M, Feijoo JF. Is oral bisphosphonate-related osteonecrosis
of the jaw an endemic condition? Med Hypotheses.
2012;78:315-8. |
|
|
|
|
|
5. Shirota T, Nakamura A, Matsui Y, Hatori
M, Nakamura M, Shintani S. Bisphosphonate-related
osteonecrosis of the jaw around dental implants in
the maxilla: report of a case. Clin Oral Impl
Res. 2009;20:1402-8. |
|
|
|
|
|
6. Kos M, Kuebler JF, Luczak K, Engelke W. Bisphosphonate-related
osteonecrosis of the jaws: A review of 34 cases and
evaluation of risk. J Craniomaxillofac
Surg. 2010;38:255-9. |
|
|
|
|
|
7. Russell
RGG. Bisphosphonates: The first 40 years.
Bone. 2011;49:2-19. |
|
|
|
|
|
8. Bedogni A, Bettini G, Totola A, Saia G, Nocini PF. Oral Bisphosphonate–associated
osteonecrosis of the jaw after implant surgery: A
case report and literature review. J Oral Maxillofac Surg. 2010;68:1662-6. |
|
|
|
|
|
9. Assael LA. Oral Bisphosphonates
as a cause of bisphosphonate-related osteonecrosis of the jaws: Clinical findings, assessment
of risks, and preventive strategies. J Oral Maxillofac Surg. 2009;67:35-43. |
|
|
|
|
|
10. Ruggiero
SL, Mehrotra B, Rosenberg
TJ, Engroff SL. Osteonecrosis of the Jaws Associated with
the Use of Bisphosphonates: A Review of 63 Cases. J Oral Maxillofac Surg.
2004;62:527-34. |
|
|
|
|
|
11. Pazianas M, Miller P, Blumentals
WA, Bernal M, Kothawala P. A Review of the
Literature on Osteonecrosis of the Jaw in patients
with osteoporosis treated with oral bisphosphonates:
Prevalence, risk factors, and clinical characteristics. Clin Ther. 2007;29:1548-58. |
|
|
|
|
|
12. Lo JC,
O'Ryan FS, Gordon NP, Yang J, Hui
RL, Martin D, et al. Prevalence of osteonecrosis of
the jaw in patients with oral bisphosphonate
exposure. J Oral Maxillofac Surg. 2010;68:243-53. |
|
|
|
|
|
13. Malden
N, Lopes V. An epidemiological study of alendronate-related osteonecrosis
of the jaws. A case series from the south-east of Scotland with attention
given to case definition and prevalence. J Bone Miner Metab. 2012;30:171-82. |
|
|
|
|
|
14. Sedghizadeh PP, Stanley K, Caligiuri
M, Hofkes S, Lowry B, Shuler CF. Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: An institutional inquiry. J Am
Dental Assoc. 2009;140:61-6. |
|
|
|
|
|
15. Migliorati CA, Mattos K, Palazzolo MJ. How patients' lack of knowledge about oral bisphosphonates can interfere with medical and dental
care. J Am Dental Assoc. 2010;141:562-6. |
|
|
|
|
|
16. Gueiros
LA, Lopes MA, Leão JC. Paget's disease and bisphosphonate-associated osteonecrosis
of the jaws. J Oral Maxillofac
Surg. 2008;66:1319. |
|
|
|
|
|
17. Malmgren B, Astrom E, Soderhall S. No osteonecrosis
in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates.
J Oral Pathol Med. 2008;37:196–200. |
|
|
|
|
|
18. Conte-Neto
N, Bastos AS, Spolidorio LC, Marcantonio
RA, Marcantonio E Jr. Oral bisphosphonate-related
osteonecrosis of the jaws in rheumatoid arthritis
patients: a critical discussion and two case reports. Head Face Med. 2011;7:1-7. |
|
|
|
|
|
19. Conte-Neto
N, Bastos AS, Marcantonio RAC, Junior EM. Epidemiological aspects of
rheumatoid arthritis patients affected by oral bisphosphonate-related
osteonecrosis of the jaws. Head Face Med. 2012;8:1-5. |
|
|
|
|
|
20. Manfredi M, Merigo E, Guidotti R, Meleti M, Vescovi P. Bisphosphonate-related
osteonecrosis of the jaws: a case series of 25
patients affected by osteoporosis. Int J Oral Maxillofac Surg. 2011;40:277-84. |
|
|
|
|
|
21. Ruggiero
SL, Dodson TB, Assael LA,
Landesberg R, Marx RE, Mehrotra
B, et al. American
Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis
of the jaw – 2009 Update. Aust Endod J. 2009;35:119-30. |
|
|
|
|
|
22. Marx RE, Cillo
JE, Ulloa JJ. Oral Bisphosphonate-Induced osteonecrosis:
Risk factors, prediction of risk using serum CTX testing, prevention, and
treatment. J Oral Maxillofac Surg. 2007;65:2397-410. |
|
|
|
|
|
23. Wutzl A, Pohl S, Sulzbacher I, Seemann R, Lauer G, Ewers R, et al. Factors influencing
surgical treatment of bisphosphonate-related osteonecrosis of the jaws. Head
Neck. 2012;34:194-200. |
|
|
|
|
|
24.
Aguirre JI, Altman MK, Vanegas SM, Franz SE, Bassit AC, Wronski TJ. Effects
of alendronate on bone healing after tooth
extraction in rats. Oral Dis.
2010;16:674-85. |
|
|
|
|
|
25. Kim
JH, Park YB, Li Z, Shim JS, Moon HS, Jung HS, et al. Effect of alendronate on healing of extraction sockets and healing
around implants. Oral Dis.
2011;17:705-11. |
|
|
|
|
|
26. Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features,
predisposing factors and treatment outcome. Osteoporos Int.
2007;18:1363-70. |
|
|
|
|
|
27. Diniz-Freitas M, López-Cedrún
JL, Fernández-Sanromán J, García-García
A, Fernández-Feijoo J, Diz-Dios
P. Oral bisphosphonate-related osteonecrosis
of the jaws: Clinical characteristics of a series of 20 cases in Spain. Med Oral
Patol Oral Cir Bucal. 2012;17:e751-8. |
|
|
|
|
|
28.
Fantasia JE. Bisphosphonates - What the dentist
needs to know: Practical considerations. J Oral Maxillofac Surg. 2009;67:53-60. |
|
|
|
|
|
29. Lo JC, O'Ryan
F, Yang J, Hararah MK, Gonzalez
JR, Gordon N, et al. Oral health considerations in older women receiving oral bisphosphonate therapy. J Am Geriatr
Soc. 2011;59:916-22. |
|
|
|
|
|
30. Saia
G, Blandamura S, Bettini
G, Tronchet A, Totola A, Bedogni G, et al. Occurrence of bisphosphonate-related
osteonecrosis of the jaw after surgical tooth
extraction. J Oral Maxillofac
Surg. 2010;68:797-804. |
|
|
|
|
|
31. Jeffcoat MK. Safety of oral bisphosphonates:
Controlled studies on alveolar bone. Int J Oral Maxillofac
Implants. 2006;21:349-53. |
|
|
|
|
|
32. Martin
DC, O'Ryan FS, Indresano
AT, Bogdanos P, Wang B, Hui
RL, et al. Characteristics of implant failures in patients with a history of
oral bisphosphonate therapy. J Oral Maxillofac Surg.
2010;68:508-14. |
|
|
|
|
|
33. Grant
BT, Amenedo C, Freeman K, Kraut RA. Outcomes of
placing dental implants in patients taking oral bisphosphonates:
A review of 115 cases. J Oral Maxillofac
Surg. 2008;66:223-30. |
|
|
|
|
|
34. Fugazzotto PA, Lightfoot AS, Jaffin R, Kumar
A. Implant placement with or without simultaneous tooth extraction in
patients taking oral bisphosphonates: Postoperative
healing, early follow-up, and the incidence of complications in two private
practices. J Periodontol. 2007;78:1664-9. |
|
|
|
|
|
35. López-Jornet P, Camacho-Alonso F, Molina-Mi-ano F, Gomez-Gracia F. Bisphosphonate-associated osteonecrosis
of the jaw. Knowledge and attitudes of dentists and dental students: a
preliminary study. J Eval Clin
Pract. 2010;16:878-82. |
|
|
|
|
|
36. Kwon
YD, Kim DY, Ohe JY, Yoo
JY, Walter C. Correlation between serum C-Terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis
of the jaws. J Oral Maxillofac
Surg. 2009;67:2644-8. |
|
|
|
|
|
37.
Fleisher KE, Welch G, Kottal S, Craig RG, Saxena D, Glickman RS. Predicting risk for bisphosphonate-related osteonecrosis
of the jaws: CTX versus radiographic markers. Oral Surg
Oral Med Oral Pathol Oral Radiol
Endod. 2010;110:509-16. |
|
|
|
|
|
38. Rocha GCMA, Jaguar GC, Moreira
CR, Neves EG, Fonseca FP, Pedreira EN. Radiographic evaluation of
maxillofacial region in oncology patients treated with bisphosphonates.
Oral Surg Oral Med Oral Pathol
Oral Radiol Endod. 2012;114:S19-25. |
|
|
|
|